These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 33344188)
21. Nepafenac 0.1% versus fluorometholone 0.1% for preventing cystoid macular edema after cataract surgery. Miyake K; Ota I; Miyake G; Numaga J J Cataract Refract Surg; 2011 Sep; 37(9):1581-8. PubMed ID: 21855758 [TBL] [Abstract][Full Text] [Related]
22. Effect of preoperative topical nepafenac 0.1% on inflammatory response after uncomplicated cataract surgery in healthy subjects. Cagini C; Cerquaglia A; Pellegrino A; Iannone A; Lupidi M; Fiore T Acta Ophthalmol; 2021 Feb; 99(1):e70-e73. PubMed ID: 32558305 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of macular changes after uncomplicated phacoemulsification surgery by optical coherence tomography. Perente I; Utine CA; Ozturker C; Cakir M; Kaya V; Eren H; Kapran Z; Yilmaz OF Curr Eye Res; 2007 Mar; 32(3):241-7. PubMed ID: 17453944 [TBL] [Abstract][Full Text] [Related]
24. Cystoid and diabetic macular edema treated with nepafenac 0.1%. Hariprasad SM; Callanan D; Gainey S; He YG; Warren K J Ocul Pharmacol Ther; 2007 Dec; 23(6):585-90. PubMed ID: 18001248 [TBL] [Abstract][Full Text] [Related]
25. Comparison of macular thickness by optical coherence tomography measurements after uneventful phacoemulsification using ketorolac tromethamine, nepafenac, vs a control group, preoperatively and postoperatively. Stock RA; Galvan DK; Godoy R; Bonamigo EL Clin Ophthalmol; 2018; 12():607-611. PubMed ID: 29636596 [TBL] [Abstract][Full Text] [Related]
26. Prophylactic nepafenac and ketorolac versus placebo in preventing postoperative macular edema after uneventful phacoemulsification. Almeida DR; Khan Z; Xing L; Bakar SN; Rahim K; Urton T; El-Defrawy SR J Cataract Refract Surg; 2012 Sep; 38(9):1537-43. PubMed ID: 22795976 [TBL] [Abstract][Full Text] [Related]
27. Postoperative management in cataract surgery: nepafenac and preservative-free diclofenac compared. Ylinen P; Taipale C; Lindholm JM; Laine I; Holmström E; Tuuminen R Acta Ophthalmol; 2018 Dec; 96(8):853-859. PubMed ID: 30284393 [TBL] [Abstract][Full Text] [Related]
28. Macular thickness measured by optical coherence tomography in a healthy population before and after uncomplicated cataract phacoemulsification surgery. Cagini C; Fiore T; Iaccheri B; Piccinelli F; Ricci MA; Fruttini D Curr Eye Res; 2009 Dec; 34(12):1036-41. PubMed ID: 19958122 [TBL] [Abstract][Full Text] [Related]
29. Treatment of cystoid macular edema with the new-generation NSAID nepafenac 0.1%. Hariprasad SM; Akduman L; Clever JA; Ober M; Recchia FM; Mieler WF Clin Ophthalmol; 2009; 3():147-54. PubMed ID: 19668559 [TBL] [Abstract][Full Text] [Related]
30. Comparison between 0.1% Nepafenac and 1% Prednisolone Eye Drop in Postoperative Management Following Micro-incisional Cataract Surgery. Sarkar S; Bardoloi N; Deb AK Korean J Ophthalmol; 2021 Jun; 35(3):188-197. PubMed ID: 34120417 [TBL] [Abstract][Full Text] [Related]
31. Comparison of Subtenon Triamcinolone Acetonide Injection with Topical Nepafenac for the Treatment of Pseudophakic Cystoid Macular Edema. Yüksel B; Uzunel UD; Kerci SG; Sağban L; Küsbeci T; Örsel T Ocul Immunol Inflamm; 2017 Aug; 25(4):513-519. PubMed ID: 27015572 [TBL] [Abstract][Full Text] [Related]
32. Retinal Vascular Caliber Changes After Topical Nepafenac Treatment for Diabetic Macular Edema. Evliyaoğlu F; Akpolat Ç; Kurt MM; Çekiç O; Nuri Elçioğlu M Curr Eye Res; 2018 Mar; 43(3):357-361. PubMed ID: 29120250 [TBL] [Abstract][Full Text] [Related]
33. Clinical Course of Pseudophakic Cystoid Macular Edema Treated with Nepafenac. Aaronson A; Achiron A; Tuuminen R J Clin Med; 2020 Sep; 9(9):. PubMed ID: 32967137 [TBL] [Abstract][Full Text] [Related]
34. Comparison of Once-Daily Bromfenac 0.07% Versus Once-Daily Nepafenac 0.3% in Patients Undergoing Phacoemulsification. Toyos MM Ophthalmol Ther; 2019 Jun; 8(2):261-270. PubMed ID: 30868419 [TBL] [Abstract][Full Text] [Related]
35. Effect of nepafenac on the foveal profile of glaucomatous patients undergoing phacoemulsification. Milla E; Stirbu O; Franco IJ; Hernández SJG; Rios J; Duch S Int Ophthalmol; 2017 Oct; 37(5):1147-1153. PubMed ID: 27771823 [TBL] [Abstract][Full Text] [Related]
36. Incidence of cystoid macular edema following routine cataract surgery using NSAIDs alone or with corticosteroids. Walter KA; Lee RY; Chen K; Komanski C Arq Bras Oftalmol; 2020; 83(1):55-61. PubMed ID: 31664337 [TBL] [Abstract][Full Text] [Related]
37. Prevalence of optical coherence tomography-diagnosed postoperative cystoid macular oedema in patients following uncomplicated phaco-emulsification cataract surgery. Vukicevic M; Gin T; Al-Qureshi S Clin Exp Ophthalmol; 2012 Apr; 40(3):282-7. PubMed ID: 21718410 [TBL] [Abstract][Full Text] [Related]
38. Topical nepafenac for prevention of post-cataract surgery macular edema in diabetic patients: patient selection and perspectives. Yüksel B; Karti Ö; Kusbeci T Clin Ophthalmol; 2017; 11():2183-2190. PubMed ID: 29269999 [TBL] [Abstract][Full Text] [Related]
39. How does nepafenac affect the choroidal thickness after uneventful cataract surgery? Cevher S; Aydoğdu G Eur J Ophthalmol; 2021 Sep; 31(5):2319-2328. PubMed ID: 33251832 [TBL] [Abstract][Full Text] [Related]
40. Additive Effect of Oral Steroid with Topical Nonsteroidal Anti-inflammatory Drug for Preventing Cystoid Macular Edema after Cataract Surgery in Patients with Epiretinal Membrane. Kim S; Kim MK; Wee WR Korean J Ophthalmol; 2017 Oct; 31(5):394-401. PubMed ID: 28913997 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]